MRK

Merck & Co., Inc. (MRK)

Last Price$97.9(2.8%)
Market Cap$247.9B
LTM P/E
20.4x
EPS growth
714.2%
PEGY
0.0x
Peter Lynch Fair Value
$3,441.7
Undervalued (Peter Lynch formula)
3,414.8%
Stock quality
7/10
Good

MRK Peter Lynch Fair Value

Crunching data... Almost there!

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

MRK EPS growth & Dividend Yield

Crunching data... Almost there!

MRK vs Peer Set: Peter Lynch Fair Value Comparison

Crunching data... Almost there!

Explore more intrinsic value tools hub for MRK

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

What is Merck & Co., Inc. fair value by Peter Lynch formula?

As of Jan 17, 2025, Merck & Co., Inc.'s fair value using the Peter Lynch formula is $3,441.7 per share. The current price of $97.9 suggests Merck & Co., Inc. may be undervalued by this metric.

What is Merck & Co., Inc. Price to Earnings (P/E) ratio?

As of Jan 17, 2025, Merck & Co., Inc.'s P/E ratio is 20.4x. This is calculated by dividing the current share price of $97.9 by the Earnings per Share (EPS) for the trailing twelve months, which is $4.8. The P/E ratio indicates how much investors are willing to pay for each dollar of earnings.

What is Merck & Co., Inc. earnings per share (EPS)?

Merck & Co., Inc. earnings per share (EPS) for the twelve months ending Jan 17, 2025, was $4.8, a 714.2% growth year-over-year.